Related Experiment Video
Updated: Jul 2, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Isolated populations and complex disease gene identification
Kati Kristiansson1, Jussi Naukkarinen, Leena Peltonen
1National Public Health Institute and FIMM, Institute for Molecular Medicine Finland, Helsinki 00300, Finland.
Genetically isolated populations are valuable for studying both rare and common diseases. These unique groups aid in gene mapping and understanding gene-environment interactions for complex traits.
Area of Science:
- Human genetics
- Population genetics
- Disease research
Background:
- Genetically isolated populations offer unique advantages for genetic research.
- These populations can be instrumental in identifying genes associated with various diseases.
Purpose of the Study:
- To highlight the utility of population isolates in genetic studies.
- To emphasize their role in understanding common diseases and traits.
Main Methods:
- Utilizing well-characterized human population samples.
- Employing genetic investigation techniques like genome-wide association studies.
- Characterizing gene-environment interactions within these populations.
Main Results:
- Population isolates are effective for gene mapping and identification.
- They provide insights into the genetic basis of common diseases and traits.
- Facilitate the study of gene-environment interactions.
Conclusions:
- Genetically isolated populations are a powerful resource for genetic research.
- Their application extends beyond rare diseases to common complex traits.
- Essential for comprehensive genetic and environmental interaction studies.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Gene Evolution - Fast or Slow?
In contrast, regions which code...
Modern Molecular Taxonomy
Evolutionary Relationships through Genome Comparisons
Pharmacogenomics: Identification of New Drug Targets
Single Nucleotide Polymorphisms-SNPs

